Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,917 | -8,714 | -17,647 | -25,138 | -18,079 |
| Depreciation Amortization | 275 | 134 | 369 | 268 | 213 |
| Accounts receivable | N/A | N/A | -14,469 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | -332 | N/A | N/A |
| Other Working Capital | 28,584 | 38,907 | 63,537 | 77,269 | 35,780 |
| Other Operating Activity | 2,409 | 1,012 | 18,296 | 2,049 | 1,335 |
| Operating Cash Flow | $22,351 | $31,339 | $49,754 | $54,448 | $19,249 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -808 | -414 | -1,950 | -1,131 | -842 |
| Purchase Of Investment | -67,222 | -11,479 | -43,925 | N/A | N/A |
| Sale Of Investment | 10,974 | 3,600 | N/A | N/A | N/A |
| Investing Cash Flow | $-57,056 | $-8,293 | $-45,875 | $-1,131 | $-842 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 48,228 | 48,159 | 4,090 | 3,493 | 1,287 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 178 |
| Financing Cash Flow | $48,228 | $48,159 | $4,090 | $3,493 | $1,465 |
| Exchange Rate Effect | -825 | 438 | 553 | 3,755 | 1,096 |
| Beginning Cash Position | 37,878 | 37,878 | 29,356 | 29,356 | 29,356 |
| End Cash Position | 50,576 | 109,521 | 37,878 | 89,921 | 50,324 |
| Net Cash Flow | $12,698 | $71,643 | $8,522 | $60,565 | $20,968 |
| Free Cash Flow | |||||
| Operating Cash Flow | 22,351 | 31,339 | 49,754 | 54,448 | 19,249 |
| Capital Expenditure | -808 | -414 | -1,950 | -1,131 | -842 |
| Free Cash Flow | 21,543 | 30,925 | 47,804 | 53,317 | 18,407 |